Story
Goldman Sachs Names CVC, ICG, and flatexDEGIRO Top European Stock Picks for Q4

Summary
Goldman Sachs has identified a group of European capital-markets stocks as top Q4 picks, citing catalysts like improving private-market exits and rising retail participation. The bank's report highlights significant potential upside for firms including CVC, ICG, and flatexDEGIRO.
Goldman Sachs has identified a select group of European capital-markets stocks, including CVC Capital Partners, ICG, and flatexDEGIRO, as top picks for the fourth quarter. The investment bank's analysts cite improving private-market activity and growing investor participation as key tailwinds for the sector.
Key Selections and Market Catalysts
In a new research note, Goldman Sachs outlined a positive outlook for European firms poised to benefit from several key market trends. The bank highlighted an expected improvement in private-market exits, record flows into passive investments, and rising retail investor participation as primary drivers.
The report assigned 'Buy' ratings to a list of companies expected to capitalize on these themes. The preferred names include CVC Capital Partners, ICG, flatexDEGIRO, London Stock Exchange Group, EQT, Eurazeo, FinecoBank, Nordnet, and Swissquote.
AdSpotlight on High-Conviction Names
Among its preferred stocks, Goldman Sachs detailed significant potential upside based on specific company catalysts. The analysis pointed to several names with implied upsides of over 60% from their reference prices.
- flatexDEGIRO: The German online broker was noted for having the largest potential upside of 66%, with a price target of €49. Goldman identified German pension reform, new product launches, and a February 2027 strategy update as potential catalysts.
- CVC Capital Partners: The private equity firm has an implied upside of 63% to Goldman's €20 price target. The bank anticipates that the firm's €26 billion Fund X will enhance visibility on future management fees, while a recovery in private-equity exit activity could bolster performance fees.
- ICG (Intermediate Capital Group): Described as a 'key Buy idea', ICG carries a 60% implied upside to a 2,930p target. Analysts pointed to stronger-than-consensus fundraising, falling leverage, and the prospect of achieving a net cash position, which would increase flexibility for capital returns.
- London Stock Exchange Group: LSEG was also favored, with a price target of 13,140p implying a 61% upside. While positive on the exchange operator and data provider, the report also acknowledged potential risks, including competition, trading volumes, regulation, and the execution of synergies.
Read next
More on Stocks
Disney Plans Major TV Division Restructuring, Hundreds of Jobs at Risk
The Walt Disney Company is set to overhaul its television business by consolidating divisions, a move expected to result in hundreds of layoffs as part of a broader cost-cutting drive. Disney shares fell more than 3% on the report.

Disney Reportedly Plans Major Restructuring of Television Business
The Walt Disney Company is planning a significant overhaul of its television division that could lead to hundreds of layoffs and the consolidation of units, The Wall Street Journal reported.

Grindr Stock Tumbles Nearly 8% on Concerns Over Telehealth Acquisition
Shares of the social networking app fell sharply as investors reacted negatively to its first major acquisition, a $250 million deal for telehealth provider PurposeMed, citing concerns over dilution, liquidity, and near-term margin pressure.

Raymond James Swaps Healthcare Top Picks for October, Adds UnitedHealth, Xencor, and Calyxt
Investment firm Raymond James has revised its Healthcare Top Picks list for October, adding UnitedHealth, Xencor, and Calyxt while removing three others. The firm cited upcoming catalysts and attractive valuations as key drivers for the changes.